Condition
Hypoplastic Left Heart
Total Trials
6
Recruiting
1
Active
1
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results80% success
Data Visualizations
Phase Distribution
3Total
P 1 (3)
Trial Status
Completed4
Terminated1
Recruiting1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04106479Recruiting
NIRS in Congenital Heart Defects - Correlation With Echocardiography
NCT04090697Phase 1TerminatedPrimary
Use of Oxandrolone to Promote Growth in Infants With HLHS
NCT03678909CompletedPrimary
Cardiac Biomarkers in Patients With Single Ventricle Physiology
NCT00576381Phase 1Completed
Understanding Dexmedetomidine in Neonates After Open Heart Surgery
NCT00573066Phase 1CompletedPrimary
Understanding Dexmedetomidine In Infants Post-Operative From Cardiac Surgery
NCT00166101CompletedPrimary
NIRS in Neonatal Cardiac Surgery
Showing all 6 trials